Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment With Northway ...

RBA Wealth Management LLC lifted its position in Accenture plc (NYSE:ACN – Free Report) by 7.4% during the 4th quarter, ...

Cullinan Associates Inc. reduced its stake in shares of Accenture plc (NYSE:ACN – Free Report) by 10.4% during the fourth ...

Clear Creek Financial Management LLC trimmed its stake in Accenture plc (NYSE:ACN – Free Report) by 14.5% during the fourth ...

A blood-based test (Freenome) may provide a new option for colorectal cancer (CRC) screening in the average-risk U.S.

Shares of Accenture plc (NYSE:ACN – Get Free Report) have earned a consensus rating of “Moderate Buy” from the twenty-three ...

Big data is changing the game, and data analytics companies are shaping the future of business intelligence. Amid this ...

Despite DeepSeek and Qwen 2.5 disrupting the global tech sector, investors welcomed the impressive Q4 AI revenues from ...

Accenture (ACN) closed the most recent trading day at $384.95, moving +1.1% from the previous trading session. The stock exceeded the S&P 500, which registered a loss of 0.51% for the day. At the same ...

In a report released today, Jason Kupferberg from Bank of America Securities maintained a Buy rating on Accenture (ACN – Research Report). The ...

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Accenture (ACN – Research Report) and Itron ...

In the latest market close, Accenture (ACN) reached $380.75, with a +1.69% movement compared to the previous day. This change outpaced the S&P 500's 0.53% gain on the day. Elsewhere, the Dow gained 0.